» Articles » PMID: 20738845

The Liposoluble Proteome of Mycoplasma Agalactiae: an Insight into the Minimal Protein Complement of a Bacterial Membrane

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2010 Aug 27
PMID 20738845
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mycoplasmas are the simplest bacteria capable of autonomous replication. Their evolution proceeded from gram-positive bacteria, with the loss of many biosynthetic pathways and of the cell wall. In this work, the liposoluble protein complement of Mycoplasma agalactiae, a minimal bacterial pathogen causing mastitis, polyarthritis, keratoconjunctivitis, and abortion in small ruminants, was subjected to systematic characterization in order to gain insights into its membrane proteome composition.

Results: The selective enrichment for M. agalactiae PG2T liposoluble proteins was accomplished by means of Triton X-114 fractionation. Liposoluble proteins were subjected to 2-D PAGE-MS, leading to the identification of 40 unique proteins and to the generation of a reference 2D map of the M. agalactiae liposoluble proteome. Liposoluble proteins from the type strain PG2 and two field isolates were then compared by means of 2D DIGE, revealing reproducible differences in protein expression among isolates. An in-depth analysis was then performed by GeLC-MS/MS in order to achieve a higher coverage of the liposoluble proteome. Using this approach, a total of 194 unique proteins were identified, corresponding to 26% of all M. agalactiae PG2T genes. A gene ontology analysis and classification for localization and function was also carried out on all protein identifications. Interestingly, the 11.5% of expressed membrane proteins derived from putative horizontal gene transfer events.

Conclusions: This study led to the in-depth systematic characterization of the M. agalactiae liposoluble protein component, providing useful insights into its membrane organization.

Citing Articles

Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies.

Barbosa M, Sampaio B, Spergser J, Rosengarten R, Marques L, Chopra-Dewasthaly R Vaccines (Basel). 2024; 12(2).

PMID: 38400139 PMC: 10892753. DOI: 10.3390/vaccines12020156.


Eating the Enemy: Mycoplasma Strategies to Evade Neutrophil Extracellular Traps (NETs) Promoting Bacterial Nucleotides Uptake and Inflammatory Damage.

Cacciotto C, Alberti A Int J Mol Sci. 2022; 23(23).

PMID: 36499356 PMC: 9740415. DOI: 10.3390/ijms232315030.


Novel Candidates for Vaccine Development Against Subspecies (Mccp)-Current Knowledge and Future Prospects.

Yatoo M, Parray O, Bhat R, Nazir Q, Haq A, Malik H Vaccines (Basel). 2019; 7(3).

PMID: 31340571 PMC: 6789616. DOI: 10.3390/vaccines7030071.


Characterization of Mycoplasma gallisepticum pyruvate dehydrogenase alpha and beta subunits and their roles in cytoadherence.

Qi J, Zhang F, Wang Y, Liu T, Tan L, Wang S PLoS One. 2018; 13(12):e0208745.

PMID: 30532176 PMC: 6287819. DOI: 10.1371/journal.pone.0208745.


Proteomics identification and characterization of MbovP730 as a potential DIVA antigen of .

Khan F, Zhao G, Guo Y, Faisal M, Chao J, Chen X Oncotarget. 2018; 9(47):28322-28336.

PMID: 29983863 PMC: 6033335. DOI: 10.18632/oncotarget.22265.


References
1.
Citti C, Droesse M, Wise K . Gene families encoding phase- and size-variable surface lipoproteins of Mycoplasma hyorhinis. J Bacteriol. 2000; 182(5):1356-63. PMC: 94424. DOI: 10.1128/JB.182.5.1356-1363.2000. View

2.
Gotz S, Garcia-Gomez J, Terol J, Williams T, Nagaraj S, Nueda M . High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008; 36(10):3420-35. PMC: 2425479. DOI: 10.1093/nar/gkn176. View

3.
Henrich B, Hopfe M, Kitzerow A, HADDING U . The adherence-associated lipoprotein P100, encoded by an opp operon structure, functions as the oligopeptide-binding domain OppA of a putative oligopeptide transport system in Mycoplasma hominis. J Bacteriol. 1999; 181(16):4873-8. PMC: 93974. DOI: 10.1128/JB.181.16.4873-4878.1999. View

4.
Tola S, Idini G, Manunta D, Galleri G, Angioi A, Rocchigiani A . Rapid and specific detection of Mycoplasma agalactiae by polymerase chain reaction. Vet Microbiol. 1996; 51(1-2):77-84. DOI: 10.1016/0378-1135(96)00023-5. View

5.
Hopfe M, Henrich B . OppA, the substrate-binding subunit of the oligopeptide permease, is the major Ecto-ATPase of Mycoplasma hominis. J Bacteriol. 2004; 186(4):1021-928. PMC: 344229. DOI: 10.1128/JB.186.4.1021-1028.2004. View